These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3964875)

  • 1. Estimation of ABO(H) isoantigen expression in bladder tumors.
    Srinivas V; Orihuela E; Lloyd KO; Old LJ; Whitmore WF
    J Urol; 1985 Jan; 133(1):25-8. PubMed ID: 3964875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood group isoantigen deletion in carcinoma in situ of the urinary bladder.
    Weinstein RS; Alroy J; Farrow GM; Miller AW; Davidsohn I
    Cancer; 1979 Feb; 43(2):661-8. PubMed ID: 421187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of A, B and H(O) antigens in normal and neoplastic epithelium of the urinary bladder by the specific red cell adherence test (SRCA).
    Kato T
    Tohoku J Exp Med; 1977 Mar; 121(3):239-46. PubMed ID: 857340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of isoantigen in the management of the urinary bladder tumor--a basic study of ABO isoantigen in step sections of the entire bladder].
    Ogawa T; Sugimoto M; Hamami G; Kamidono S
    Hinyokika Kiyo; 1989 Jan; 35(1):13-25. PubMed ID: 2729014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood group isoantigen deletion and chromosomal abnormalities in bladder cancer.
    Pauwels RP; Schapers RF; Smeets AW; Jansen LE; Debruyne FM; Geraedts JP
    J Urol; 1988 Nov; 140(5):959-63. PubMed ID: 3050155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of A, B or O (H) surface antigen specificity: carcinoma in situ and non-malignant lesions of the bladder.
    Emmott RC; Droller MJ; Javadpour N
    J Urol; 1981 Jan; 125(1):32-5. PubMed ID: 6162036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ABH isoantigen of superficial urothelial tumor and carcinoma in situ of the bladder by the avidin-biotin peroxidase complex(ABC) method].
    Sasaki K
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1326-38. PubMed ID: 6374223
    [No Abstract]   [Full Text] [Related]  

  • 9. A, B and O(H) isoantigens in tumor of the urinary bladder. Preliminary results, relating the specific red cell adherence test to pathological grade and stage.
    Karlsen S; Jordfald G; Svaar H
    Urol Int; 1984; 39(3):150-3. PubMed ID: 6740805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma in situ of the bladder.
    Hudson MA; Herr HW
    J Urol; 1995 Mar; 153(3 Pt 1):564-72. PubMed ID: 7861485
    [No Abstract]   [Full Text] [Related]  

  • 12. [The study of the ABH isoantigen of bladder tumors].
    Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of blood group antigens and carcinoembryonic antigen in urinary bladder carcinoma.
    Fujioka T; Ohhori T; Lovrekovich L; deKernion JB
    Urol Int; 1986; 41(6):397-402. PubMed ID: 3547992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood group antigens in epithelial tumours of the urinary bladder.
    Marek J; Hradec E; Hanus M; Smolová H
    Czech Med; 1988; 11(3):137-45. PubMed ID: 3147171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic detection and prognosis of patients with transitional cell carcinoma of the urinary bladder.
    Tan LB; Lin LM; Huang CH; Chiang CP; Chien CH; Pan CC
    Urol Int; 1989; 44(5):264-71. PubMed ID: 2800062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of ABO(H) isoantigens in urinary bladder tumours.
    Baranyay F; Knels R; Somogyi L
    Acta Med Hung; 1992-1993; 49(1-2):129-36. PubMed ID: 1296182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.